340B Unscripted

Ep 91 | More 340B Updates

47 min · 4 de may de 2026
portada del episodio Ep 91 | More 340B Updates

Descripción

In this episode, Greg and Rob catch up on more recent developments across the 340B community. They discuss recent Congressional activity where 340B has been a focus, a shift in court rulings related to state contract pharmacy laws, and they catch up on recent litigation over 340B child site eligibility timing, GPO Prohibition policies, and patient definition. They round out the discussion by recapping developments with manufacturer contract pharmacy restrictions and claim-level data submission policies. Email us questions at 340BUnscripted@spendmend.com [340BUnscripted@spendmend.com]

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y forma parte de la comunidad de 340B Unscripted!

Prueba gratis

Empieza 7 días de prueba

$99 / mes después de la prueba. · Cancela cuando quieras.

  • Podcasts solo en Podimo
  • 20 horas de audiolibros al mes
  • Podcast gratuitos

Todos los episodios

94 episodios

episode Ep 89 | 340B Pricing Removal & GPO Prohibition Court Case Ruling artwork

Ep 89 | 340B Pricing Removal & GPO Prohibition Court Case Ruling

In this episode, Greg and Rob discuss reports of 340B pricing removal from wholesaler accounts, which may be related to recent manufacturer claim submission requirement policies.  They also catch up on some developments in state-level contract pharmacy laws, including Washington’s newly passed state law that incorporates contract pharmacy provisions, as well as reporting requirements for both providers and manufacturers. As a bonus, Nick Gnadt joins at the end to share an update on a recent court ruling (Premier v HHS) in which a judge vacated the 2013 HRSA GPO Prohibition Policy Notice. Premier, Inc. v HRSA DC District Court Ruling:  https://cases.justia.com/federal/district-courts/district-of-columbia/dcdce/1:2024cv03116/274475/23… [https://cases.justia.com/federal/district-courts/district-of-columbia/dcdce/1:2024cv03116/274475/23%E2%80%A6] Questions for us? Email us at 340BUnscripted@spendmend.com [340BUnscripted@spendmend.com]

6 de abr de 202651 min